The Food and Drug Administration has approved a generic version of Teva Women's Health's Plan B One-Step, an emergency contraceptive that is availble over-the-counter without a prescription for women age 17 and older.
Watson Pharmaceuticals announced Friday that the FDA approved its Next Choice ONE DOSE, a lower-cost generic version that will launch "immediately," according to a press release.
Plan B One-Step sales took in $88 million for the 12 months ending May 31, according to IMS Health Data.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
